Purchase Order 75F40123P00075
Award Date 4/3/23
Potential Completion Date 4/2/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) has awarded a $749,661.00 firm fixed-price definitive contract to Duke University, a prestigious private research institution located in Durham, North Carolina. The contract is not set-aside and was issued under the FDA's Fiscal Year 2025 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. The BAA solicits basic and applied research and development proposals to support the FDA's mission of protecting and promoting...
- The U.S. Food and Drug Administration (FDA) awarded a $696,359 firm-fixed-price contract to Duke University's Office of Research Administration Division to conduct research and development activities in support of regulatory science and innovation. The contract, which does not have a set-aside designation, originated from a Broad Agency Announcement (BAA) that solicits advanced proposals across nine key areas to advance scientific knowledge in support of the FDA's mission to protect public...
- The U.S. Food and Drug Administration (FDA) has awarded a $1,567,108.00 definitive cost-no-fee contract to Duke University to conduct a study on Medicare Advantage for real-world evidence in cardiovascular disease. The contract has an ultimate completion date of September 29, 2026. Duke University, a prominent private research university, will be the prime contractor for this effort, which is not set aside under any special program. The contract award indicates Duke University's extensive...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Duke University on September 25, 2023. The contract, valued at $220,108.00, is for the "Conduct of In Vitro Cardiovascular Toxicity Assays for the Division of Translational Toxicology" and has a completion date of December 31, 2024. The contract does not have a set-aside designation. Duke University's Office of Research Administration...
- Duke University Office of Research Administration Division was awarded a $274,413 definitive contract by the Department of Health and Human Services Food and Drug Administration to conduct a study using electronic health records to identify and assess adverse events for biologic therapies. The contract aims to develop and validate methodological approaches under the agency's Broad Agency Announcement for the Advanced Research and Development of Regulatory Science, which seeks proposals to...
- This is a $1,206,589.24 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Duke University's Office of Research Administration Division. The contract is for research and development to quantify patient priorities for clinical evidence on the impact of osseointegrated limb prostheses. This award was made under the FDA's Broad Agency Announcement for regulatory science and innovation research, with no set-aside designation. Duke University has previously received...
- This federal contract was awarded to Duke University by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to support the development and deployment of COVID-19 vaccines under Operation Warp Speed. The $281,376.08 definitive cost-no-fee contract, awarded on September 17, 2021, does not have a set-aside designation. The contract supports research and development activities to advance regulatory science and innovation, which aligns with Duke University's expertise...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University, a private non-profit research institution, for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The $106,491.59 delivery order contract has an ultimate completion date of December 14, 2020 and does not have a set-aside designation. This award is part of a larger master Indefinite Delivery Vehicle (IDV) contract focused on...
- Duke University's Office of Research Administration was awarded a $1,056,338 firm fixed-price contract by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to establish a partnership with the Biomedical Advanced Research and Development Authority (BARDA) aimed at enhancing innovation in clinical research. The contract, executed on September 29, 2024, with a completion date of September 28, 2029, will be performed in Durham, North Carolina. This definitive contract...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 6 to Duke University, a private research university located in Durham, North Carolina. The $83,035.00 contract is for laboratory services to conduct targeted mass spectrometry and protein profiling analysis on liver tissue samples as part of a research and development study into plasma-based signatures following hepatitis C virus cure in veterans with severe liver disease....